Freenome's Series B Round

Freenome raised a round of funding on July 24, 2019.

Freenome is an AI genomics biotechnology company in South San Francisco, California. By using a blood test, Freenome can help detect and treat cancer quickly and efficiently.…

Articles about Freenome's Series B Round: